nodes	percent_of_prediction	percent_of_DWPC	metapath
Naloxone—ESR1—periosteum—cleft lip	0.016	0.2	CbGeAlD
Naloxone—CREB1—mouth—cleft lip	0.0116	0.145	CbGeAlD
Naloxone—CREB1—embryo—cleft lip	0.00825	0.103	CbGeAlD
Naloxone—CREB1—telencephalon—cleft lip	0.00671	0.084	CbGeAlD
Naloxone—OPRD1—telencephalon—cleft lip	0.0053	0.0664	CbGeAlD
Naloxone—CREB1—head—cleft lip	0.00418	0.0523	CbGeAlD
Naloxone—OPRM1—telencephalon—cleft lip	0.00362	0.0453	CbGeAlD
Naloxone—OPRD1—head—cleft lip	0.0033	0.0413	CbGeAlD
Naloxone—ESR1—embryo—cleft lip	0.00325	0.0406	CbGeAlD
Naloxone—OPRK1—head—cleft lip	0.00317	0.0396	CbGeAlD
Naloxone—SLCO1A2—telencephalon—cleft lip	0.00311	0.039	CbGeAlD
Naloxone—ESR1—telencephalon—cleft lip	0.00264	0.033	CbGeAlD
Naloxone—OPRM1—head—cleft lip	0.00225	0.0282	CbGeAlD
Naloxone—SLCO1A2—head—cleft lip	0.00194	0.0243	CbGeAlD
Naloxone—ESR1—head—cleft lip	0.00164	0.0206	CbGeAlD
Naloxone—ESR1—Aryl Hydrocarbon Receptor—MYC—cleft lip	0.0013	0.00142	CbGpPWpGaD
Naloxone—CREB1—Signaling by NGF—FGF10—cleft lip	0.00129	0.0014	CbGpPWpGaD
Naloxone—ABCB1—Integrated Pancreatic Cancer Pathway—NODAL—cleft lip	0.00129	0.0014	CbGpPWpGaD
Naloxone—ABCB1—embryo—cleft lip	0.00128	0.0161	CbGeAlD
Naloxone—ALB—Folate Metabolism—MTHFR—cleft lip	0.00127	0.00139	CbGpPWpGaD
Naloxone—CREB1—Regulation of nuclear SMAD2/3 signaling—MYC—cleft lip	0.00126	0.00137	CbGpPWpGaD
Naloxone—OPRK1—Signaling by GPCR—WNT9B—cleft lip	0.00126	0.00137	CbGpPWpGaD
Naloxone—CREB1—NGF signalling via TRKA from the plasma membrane—FGFR1—cleft lip	0.00126	0.00136	CbGpPWpGaD
Naloxone—CREB1—Signaling by SCF-KIT—FGF2—cleft lip	0.00124	0.00135	CbGpPWpGaD
Naloxone—CREB1—B Cell Activation—FGFR3—cleft lip	0.00124	0.00135	CbGpPWpGaD
Naloxone—TLR4—Immune System—FGF10—cleft lip	0.00123	0.00134	CbGpPWpGaD
Naloxone—OPRD1—GPCR ligand binding—PTCH1—cleft lip	0.00122	0.00133	CbGpPWpGaD
Naloxone—CREB1—Disease—WNT9B—cleft lip	0.00122	0.00133	CbGpPWpGaD
Naloxone—CREB1—Innate Immune System—FGF7—cleft lip	0.00119	0.0013	CbGpPWpGaD
Naloxone—CREB1—Downstream signaling of activated FGFR—FGF2—cleft lip	0.00119	0.00129	CbGpPWpGaD
Naloxone—CREB1—NGF signalling via TRKA from the plasma membrane—FGFR3—cleft lip	0.00119	0.00129	CbGpPWpGaD
Naloxone—CREB1—Signaling by ERBB4—FGF2—cleft lip	0.00117	0.00127	CbGpPWpGaD
Naloxone—TLR4—Innate Immune System—FGF2—cleft lip	0.00115	0.00125	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—ARHGAP29—cleft lip	0.00115	0.00125	CbGpPWpGaD
Naloxone—CREB1—Signaling by GPCR—WNT3—cleft lip	0.00115	0.00125	CbGpPWpGaD
Naloxone—OPRD1—Signaling by GPCR—WNT3—cleft lip	0.00115	0.00124	CbGpPWpGaD
Naloxone—CREB1—Adaptive Immune System—FGF7—cleft lip	0.00114	0.00124	CbGpPWpGaD
Naloxone—CREB1—Myometrial Relaxation and Contraction Pathways—NOS3—cleft lip	0.00114	0.00123	CbGpPWpGaD
Naloxone—ESR1—Signaling by ERBB4—FGFR2—cleft lip	0.00113	0.00122	CbGpPWpGaD
Naloxone—CREB1—Downstream signal transduction—FGF2—cleft lip	0.00112	0.00121	CbGpPWpGaD
Naloxone—CYP2C8—Biological oxidations—MTR—cleft lip	0.00111	0.00121	CbGpPWpGaD
Naloxone—CREB1—Signaling by FGFR—FGF2—cleft lip	0.00111	0.00121	CbGpPWpGaD
Naloxone—CREB1—Immune System—IRF6—cleft lip	0.00111	0.0012	CbGpPWpGaD
Naloxone—CREB1—Signaling by ERBB2—FGF2—cleft lip	0.00111	0.0012	CbGpPWpGaD
Naloxone—CREB1—DAP12 signaling—FGF2—cleft lip	0.0011	0.0012	CbGpPWpGaD
Naloxone—CREB1—Innate Immune System—FGF8—cleft lip	0.0011	0.0012	CbGpPWpGaD
Naloxone—CREB1—EGF/EGFR Signaling Pathway—NOS3—cleft lip	0.0011	0.00119	CbGpPWpGaD
Naloxone—CREB1—B Cell Receptor Signaling Pathway—MYC—cleft lip	0.0011	0.00119	CbGpPWpGaD
Naloxone—CREB1—Disease—ABCA4—cleft lip	0.00109	0.00118	CbGpPWpGaD
Naloxone—CREB1—Downstream signaling events of B Cell Receptor (BCR)—FGF2—cleft lip	0.00108	0.00118	CbGpPWpGaD
Naloxone—OPRK1—GPCR ligand binding—PTCH1—cleft lip	0.00107	0.00117	CbGpPWpGaD
Naloxone—OPRM1—Signaling by GPCR—WNT9B—cleft lip	0.00107	0.00116	CbGpPWpGaD
Naloxone—CREB1—Adaptive Immune System—FGF8—cleft lip	0.00106	0.00115	CbGpPWpGaD
Naloxone—ESR1—Signaling by ERBB4—FGFR1—cleft lip	0.00105	0.00114	CbGpPWpGaD
Naloxone—ABCB1—telencephalon—cleft lip	0.00104	0.0131	CbGeAlD
Naloxone—CREB1—Signaling by NGF—FGFR2—cleft lip	0.00104	0.00113	CbGpPWpGaD
Naloxone—CREB1—Fc epsilon receptor (FCERI) signaling—FGF2—cleft lip	0.00104	0.00113	CbGpPWpGaD
Naloxone—CREB1—Signaling by FGFR in disease—FGF2—cleft lip	0.00104	0.00113	CbGpPWpGaD
Naloxone—CREB1—DAP12 interactions—FGF2—cleft lip	0.00104	0.00113	CbGpPWpGaD
Naloxone—ESR1—Integrated Pancreatic Cancer Pathway—TYMS—cleft lip	0.00103	0.00112	CbGpPWpGaD
Naloxone—CREB1—Signaling by EGFR—FGF2—cleft lip	0.00103	0.00112	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—ARHGAP29—cleft lip	0.00102	0.00111	CbGpPWpGaD
Naloxone—CREB1—Signaling by EGFR in Cancer—FGF2—cleft lip	0.00102	0.00111	CbGpPWpGaD
Naloxone—ALB—Selenium Micronutrient Network—MTHFR—cleft lip	0.00101	0.0011	CbGpPWpGaD
Naloxone—CREB1—Signaling by PDGF—FGF2—cleft lip	0.00101	0.0011	CbGpPWpGaD
Naloxone—OPRK1—Signaling by GPCR—WNT3—cleft lip	0.001	0.00109	CbGpPWpGaD
Naloxone—ESR1—Validated nuclear estrogen receptor alpha network—MYC—cleft lip	0.001	0.00109	CbGpPWpGaD
Naloxone—CREB1—Signaling by NOTCH—MYC—cleft lip	0.000997	0.00108	CbGpPWpGaD
Naloxone—CREB1—Disease—SLC19A1—cleft lip	0.000995	0.00108	CbGpPWpGaD
Naloxone—ESR1—Signaling by ERBB4—FGFR3—cleft lip	0.000991	0.00108	CbGpPWpGaD
Naloxone—TLR4—Immune System—FGFR2—cleft lip	0.000986	0.00107	CbGpPWpGaD
Naloxone—CREB1—Integrated Pancreatic Cancer Pathway—FGF2—cleft lip	0.000974	0.00106	CbGpPWpGaD
Naloxone—CREB1—Disease—WNT3—cleft lip	0.000969	0.00105	CbGpPWpGaD
Naloxone—CREB1—Signaling by NGF—FGFR1—cleft lip	0.000966	0.00105	CbGpPWpGaD
Naloxone—CREB1—B Cell Activation—FGF2—cleft lip	0.000958	0.00104	CbGpPWpGaD
Naloxone—ESR1—Regulation of Telomerase—MYC—cleft lip	0.000953	0.00104	CbGpPWpGaD
Naloxone—ESR1—AP-1 transcription factor network—MYC—cleft lip	0.000931	0.00101	CbGpPWpGaD
Naloxone—TLR4—Immune System—FGFR1—cleft lip	0.000919	0.000999	CbGpPWpGaD
Naloxone—CREB1—NGF signalling via TRKA from the plasma membrane—FGF2—cleft lip	0.000917	0.000997	CbGpPWpGaD
Naloxone—CREB1—Signaling by NGF—FGFR3—cleft lip	0.000913	0.000992	CbGpPWpGaD
Naloxone—OPRM1—GPCR ligand binding—PTCH1—cleft lip	0.000906	0.000985	CbGpPWpGaD
Naloxone—CREB1—Innate Immune System—FGF3—cleft lip	0.000895	0.000973	CbGpPWpGaD
Naloxone—CREB1—Axon guidance—FGFR1—cleft lip	0.000874	0.00095	CbGpPWpGaD
Naloxone—ESR1—Integrated Pancreatic Cancer Pathway—FGFR1—cleft lip	0.000874	0.000949	CbGpPWpGaD
Naloxone—CREB1—Innate Immune System—FGF9—cleft lip	0.000873	0.000949	CbGpPWpGaD
Naloxone—TLR4—Immune System—FGFR3—cleft lip	0.000868	0.000944	CbGpPWpGaD
Naloxone—CREB1—Adaptive Immune System—FGF3—cleft lip	0.00086	0.000934	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—WNT9B—cleft lip	0.000854	0.000929	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—WNT9B—cleft lip	0.000852	0.000926	CbGpPWpGaD
Naloxone—OPRM1—Signaling by GPCR—WNT3—cleft lip	0.000849	0.000922	CbGpPWpGaD
Naloxone—CREB1—Adaptive Immune System—FGF9—cleft lip	0.000838	0.000911	CbGpPWpGaD
Naloxone—ALB—Hemostasis—TGFB3—cleft lip	0.000835	0.000908	CbGpPWpGaD
Naloxone—CREB1—Developmental Biology—FGF10—cleft lip	0.000834	0.000906	CbGpPWpGaD
Naloxone—ESR1—Regulation of nuclear SMAD2/3 signaling—MYC—cleft lip	0.000828	0.0009	CbGpPWpGaD
Naloxone—CREB1—Disease—TCN2—cleft lip	0.000824	0.000896	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—NOG—cleft lip	0.000819	0.00089	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—NOG—cleft lip	0.000817	0.000887	CbGpPWpGaD
Naloxone—ALB—Transmembrane transport of small molecules—ABCA4—cleft lip	0.000769	0.000836	CbGpPWpGaD
Naloxone—CREB1—Integrated Breast Cancer Pathway—MYC—cleft lip	0.000769	0.000835	CbGpPWpGaD
Naloxone—ESR1—Signaling by ERBB4—FGF2—cleft lip	0.000766	0.000832	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—ABCA4—cleft lip	0.000762	0.000828	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—ABCA4—cleft lip	0.000759	0.000825	CbGpPWpGaD
Naloxone—CREB1—Immune System—SUMO1—cleft lip	0.000759	0.000825	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—WNT9B—cleft lip	0.000747	0.000812	CbGpPWpGaD
Naloxone—CREB1—Innate Immune System—FGF10—cleft lip	0.000736	0.0008	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—NOG—cleft lip	0.000716	0.000778	CbGpPWpGaD
Naloxone—CREB1—Adaptive Immune System—FGF10—cleft lip	0.000707	0.000768	CbGpPWpGaD
Naloxone—CREB1—Signaling by NGF—FGF2—cleft lip	0.000705	0.000766	CbGpPWpGaD
Naloxone—CREB1—Immune System—FGF7—cleft lip	0.000694	0.000754	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—WNT3—cleft lip	0.000679	0.000738	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—WNT3—cleft lip	0.000677	0.000735	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism—SLC19A1—cleft lip	0.000674	0.000733	CbGpPWpGaD
Naloxone—ABCB1—Transmembrane transport of small molecules—ABCA4—cleft lip	0.000674	0.000732	CbGpPWpGaD
Naloxone—TLR4—Immune System—FGF2—cleft lip	0.000671	0.000729	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—ABCA4—cleft lip	0.000666	0.000723	CbGpPWpGaD
Naloxone—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—cleft lip	0.000655	0.000712	CbGpPWpGaD
Naloxone—ABCB1—head—cleft lip	0.000649	0.00813	CbGeAlD
Naloxone—CREB1—Disease—SPRY2—cleft lip	0.000641	0.000697	CbGpPWpGaD
Naloxone—CREB1—Disease—FGF7—cleft lip	0.000641	0.000697	CbGpPWpGaD
Naloxone—CREB1—Immune System—FGF8—cleft lip	0.000641	0.000696	CbGpPWpGaD
Naloxone—ESR1—Integrated Pancreatic Cancer Pathway—FGF2—cleft lip	0.000638	0.000693	CbGpPWpGaD
Naloxone—CREB1—Integrated Pancreatic Cancer Pathway—MYC—cleft lip	0.000637	0.000692	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—WNT9B—cleft lip	0.000631	0.000686	CbGpPWpGaD
Naloxone—CREB1—Signaling by GPCR—PTCH1—cleft lip	0.00063	0.000684	CbGpPWpGaD
Naloxone—OPRD1—Signaling by GPCR—PTCH1—cleft lip	0.000628	0.000682	CbGpPWpGaD
Naloxone—CREB1—Developmental Biology—FGFR1—cleft lip	0.000624	0.000678	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—NOG—cleft lip	0.000605	0.000658	CbGpPWpGaD
Naloxone—CYP3A4—Biological oxidations—MTR—cleft lip	0.000597	0.000649	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—WNT3—cleft lip	0.000593	0.000645	CbGpPWpGaD
Naloxone—CREB1—Disease—FGF8—cleft lip	0.000591	0.000643	CbGpPWpGaD
Naloxone—CREB1—Innate Immune System—FGFR2—cleft lip	0.000591	0.000642	CbGpPWpGaD
Naloxone—CREB1—Disease—MTR—cleft lip	0.000571	0.000621	CbGpPWpGaD
Naloxone—CREB1—Adaptive Immune System—FGFR2—cleft lip	0.000567	0.000617	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—ABCA4—cleft lip	0.000563	0.000611	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—WNT9B—cleft lip	0.00056	0.000608	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism—TCN2—cleft lip	0.000559	0.000607	CbGpPWpGaD
Naloxone—CREB1—Innate Immune System—FGFR1—cleft lip	0.000551	0.000599	CbGpPWpGaD
Naloxone—OPRK1—Signaling by GPCR—PTCH1—cleft lip	0.00055	0.000598	CbGpPWpGaD
Naloxone—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—cleft lip	0.000546	0.000594	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—NOG—cleft lip	0.000537	0.000583	CbGpPWpGaD
Naloxone—CREB1—Adaptive Immune System—FGFR1—cleft lip	0.000529	0.000575	CbGpPWpGaD
Naloxone—CREB1—Immune System—FGF3—cleft lip	0.000521	0.000567	CbGpPWpGaD
Naloxone—CREB1—Innate Immune System—FGFR3—cleft lip	0.000521	0.000566	CbGpPWpGaD
Naloxone—CREB1—Immune System—FGF9—cleft lip	0.000508	0.000553	CbGpPWpGaD
Naloxone—ESR1—Integrated Breast Cancer Pathway—MYC—cleft lip	0.000503	0.000547	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—WNT3—cleft lip	0.000501	0.000545	CbGpPWpGaD
Naloxone—CREB1—Adaptive Immune System—FGFR3—cleft lip	0.0005	0.000543	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—ABCA4—cleft lip	0.000499	0.000542	CbGpPWpGaD
Naloxone—CREB1—Disease—FGF3—cleft lip	0.000481	0.000523	CbGpPWpGaD
Naloxone—CREB1—Disease—FGF9—cleft lip	0.000469	0.00051	CbGpPWpGaD
Naloxone—OPRM1—Signaling by GPCR—PTCH1—cleft lip	0.000465	0.000505	CbGpPWpGaD
Naloxone—ABCB1—Integrated Pancreatic Cancer Pathway—FGFR1—cleft lip	0.000462	0.000502	CbGpPWpGaD
Naloxone—CREB1—Developmental Biology—FGF2—cleft lip	0.000455	0.000495	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—FGF7—cleft lip	0.000449	0.000488	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—SPRY2—cleft lip	0.000449	0.000488	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—SPRY2—cleft lip	0.000447	0.000486	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—FGF7—cleft lip	0.000447	0.000486	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—WNT3—cleft lip	0.000445	0.000483	CbGpPWpGaD
Naloxone—CREB1—Immune System—FGF10—cleft lip	0.000429	0.000466	CbGpPWpGaD
Naloxone—ESR1—Integrated Pancreatic Cancer Pathway—MYC—cleft lip	0.000417	0.000453	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—FGF8—cleft lip	0.000414	0.00045	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—FGF8—cleft lip	0.000413	0.000449	CbGpPWpGaD
Naloxone—CREB1—Innate Immune System—FGF2—cleft lip	0.000402	0.000437	CbGpPWpGaD
Naloxone—CREB1—Disease—FGF10—cleft lip	0.000396	0.00043	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—SPRY2—cleft lip	0.000392	0.000426	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—FGF7—cleft lip	0.000392	0.000426	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism—MTR—cleft lip	0.000387	0.000421	CbGpPWpGaD
Naloxone—CREB1—Adaptive Immune System—FGF2—cleft lip	0.000386	0.00042	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—PTCH1—cleft lip	0.000372	0.000404	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—PTCH1—cleft lip	0.000371	0.000403	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—FGF8—cleft lip	0.000362	0.000393	CbGpPWpGaD
Naloxone—CREB1—Immune System—FGFR2—cleft lip	0.000344	0.000374	CbGpPWpGaD
Naloxone—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—cleft lip	0.000338	0.000367	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—FGF3—cleft lip	0.000337	0.000366	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—FGF3—cleft lip	0.000336	0.000365	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—FGF7—cleft lip	0.000332	0.00036	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—SPRY2—cleft lip	0.000332	0.00036	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—SLC19A1—cleft lip	0.000331	0.00036	CbGpPWpGaD
Naloxone—ALB—Metabolism—SLC19A1—cleft lip	0.000329	0.000358	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—FGF9—cleft lip	0.000329	0.000357	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—FGF9—cleft lip	0.000328	0.000356	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—PTCH1—cleft lip	0.000325	0.000353	CbGpPWpGaD
Naloxone—CREB1—Immune System—FGFR1—cleft lip	0.000321	0.000349	CbGpPWpGaD
Naloxone—CREB1—Disease—FGFR2—cleft lip	0.000318	0.000345	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—FGF8—cleft lip	0.000306	0.000333	CbGpPWpGaD
Naloxone—CREB1—Disease—MTHFR—cleft lip	0.000306	0.000332	CbGpPWpGaD
Naloxone—CREB1—Immune System—FGFR3—cleft lip	0.000303	0.000329	CbGpPWpGaD
Naloxone—CREB1—Disease—FGFR1—cleft lip	0.000296	0.000322	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—FGF3—cleft lip	0.000295	0.00032	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—FGF7—cleft lip	0.000294	0.000319	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—SPRY2—cleft lip	0.000294	0.000319	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—SLC19A1—cleft lip	0.000289	0.000314	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—FGF9—cleft lip	0.000287	0.000312	CbGpPWpGaD
Naloxone—CREB1—Disease—FGFR3—cleft lip	0.00028	0.000304	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—FGF10—cleft lip	0.000277	0.000301	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—FGF10—cleft lip	0.000276	0.0003	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—PTCH1—cleft lip	0.000275	0.000299	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—TCN2—cleft lip	0.000275	0.000298	CbGpPWpGaD
Naloxone—ALB—Metabolism—TCN2—cleft lip	0.000273	0.000297	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—FGF8—cleft lip	0.000271	0.000295	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—FGF3—cleft lip	0.000249	0.000271	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—PTCH1—cleft lip	0.000244	0.000265	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—FGF9—cleft lip	0.000243	0.000264	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—FGF10—cleft lip	0.000242	0.000263	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—TCN2—cleft lip	0.000239	0.00026	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism—TYMS—cleft lip	0.000237	0.000258	CbGpPWpGaD
Naloxone—CREB1—Immune System—FGF2—cleft lip	0.000234	0.000255	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—FGFR2—cleft lip	0.000223	0.000242	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—FGFR2—cleft lip	0.000222	0.000241	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—FGF3—cleft lip	0.000221	0.00024	CbGpPWpGaD
Naloxone—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—cleft lip	0.000221	0.00024	CbGpPWpGaD
Naloxone—CREB1—Disease—FGF2—cleft lip	0.000216	0.000235	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—FGF9—cleft lip	0.000215	0.000234	CbGpPWpGaD
Naloxone—CREB1—Disease—NOS3—cleft lip	0.000213	0.000232	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—FGFR1—cleft lip	0.000207	0.000225	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism—MTHFR—cleft lip	0.000207	0.000225	CbGpPWpGaD
Naloxone—ESR1—Generic Transcription Pathway—MYC—cleft lip	0.000207	0.000225	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—FGFR1—cleft lip	0.000207	0.000225	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—FGF10—cleft lip	0.000205	0.000223	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—FGFR3—cleft lip	0.000196	0.000213	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—FGFR3—cleft lip	0.000195	0.000212	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—FGFR2—cleft lip	0.000194	0.000211	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—MTR—cleft lip	0.00019	0.000207	CbGpPWpGaD
Naloxone—ALB—Metabolism—MTR—cleft lip	0.000189	0.000206	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—FGF10—cleft lip	0.000182	0.000197	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—FGFR1—cleft lip	0.000181	0.000197	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—SLC19A1—cleft lip	0.000178	0.000193	CbGpPWpGaD
Naloxone—ALB—Hemostasis—NOS3—cleft lip	0.000174	0.000189	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—FGFR3—cleft lip	0.000171	0.000186	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—MTR—cleft lip	0.000166	0.00018	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—FGFR2—cleft lip	0.000164	0.000179	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—FGFR1—cleft lip	0.000153	0.000167	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—FGF2—cleft lip	0.000151	0.000165	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—FGF2—cleft lip	0.000151	0.000164	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—NOS3—cleft lip	0.000149	0.000162	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—NOS3—cleft lip	0.000149	0.000162	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—TCN2—cleft lip	0.000147	0.00016	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—FGFR2—cleft lip	0.000146	0.000158	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—FGFR3—cleft lip	0.000145	0.000157	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism—NOS3—cleft lip	0.000145	0.000157	CbGpPWpGaD
Naloxone—CREB1—Disease—MYC—cleft lip	0.000141	0.000154	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—FGFR1—cleft lip	0.000136	0.000148	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—FGF2—cleft lip	0.000132	0.000144	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—NOS3—cleft lip	0.000131	0.000142	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—FGFR3—cleft lip	0.000128	0.00014	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—TYMS—cleft lip	0.000117	0.000127	CbGpPWpGaD
Naloxone—ALB—Metabolism—TYMS—cleft lip	0.000116	0.000126	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—FGF2—cleft lip	0.000112	0.000122	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—NOS3—cleft lip	0.00011	0.00012	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—MTR—cleft lip	0.000102	0.000111	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—MTHFR—cleft lip	0.000102	0.000111	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—TYMS—cleft lip	0.000102	0.00011	CbGpPWpGaD
Naloxone—ALB—Metabolism—MTHFR—cleft lip	0.000101	0.00011	CbGpPWpGaD
Naloxone—ESR1—Gene Expression—MYC—cleft lip	9.98e-05	0.000108	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—FGF2—cleft lip	9.92e-05	0.000108	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—MYC—cleft lip	9.9e-05	0.000108	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—MYC—cleft lip	9.87e-05	0.000107	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—NOS3—cleft lip	9.79e-05	0.000106	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—MTHFR—cleft lip	8.88e-05	9.65e-05	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—MYC—cleft lip	8.66e-05	9.41e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—MYC—cleft lip	7.32e-05	7.95e-05	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—NOS3—cleft lip	7.11e-05	7.72e-05	CbGpPWpGaD
Naloxone—ALB—Metabolism—NOS3—cleft lip	7.07e-05	7.68e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—MYC—cleft lip	6.49e-05	7.05e-05	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—TYMS—cleft lip	6.26e-05	6.8e-05	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—NOS3—cleft lip	6.19e-05	6.73e-05	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—MTHFR—cleft lip	5.47e-05	5.94e-05	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—NOS3—cleft lip	3.81e-05	4.15e-05	CbGpPWpGaD
